Skip to main content

Table 7 Variables associated with treatments received during the most recent treatment period for anxiety disordersg, h

From: Treatment adequacy of anxiety disorders among young adults in Finland

 

Pharmacotherapy

Visits with a physician / a year

Guideline-concordant pharmacotherapyc

Sessions of psychotherapy / a year

Minimally adequate treatmente

Anya

≥2 months

Anyb

≥4 times

 

Anyd

≥8 times

 

Variable

Category

OR

95 % CI

OR

95 % CI

OR

95 % CI

OR

95 % CI

OR

95 % CI

OR

95 % CI

OR

95 % CI

OR

95 % CI

Gender

Male (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

 

Female

1.19

0.34–4.14

1.06

0.29–3.90

1.95

0.50–7.64

1.16

0.30–4.56

0.72

0.18–2.87

1.18

0.31–4.47

1.50

0.38–5.92

1.18

0.33–4.18

Basic education

Less than high school (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

High school

1.33

0.42–4.18

3.08

0.86–11.04

1.42

0.41–4.97

0.92

0.25–3.35

1.57

0.40–6.09

1.04

0.31–3.45

1.12

0.32–3.94

0.71

0.22–2.30

Married or

No (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

cohabiting

Yes

0.43

0.15–1.25

0.85

0.28–2.56

0.34

0.09–1.25

*0.27

0.08–0.85

0.66

0.20–2.11

0.35

0.11–1.14

0.39

0.12–1.21

0.36

0.12–1.05

Comorbid

No (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

mood disorder

Yes

1.07

0.36–3.14

1.47

0.47–4.60

1.28

0.41–4.00

0.99

0.31–3.15

1.59

0.46–5.44

0.71

0.22–2.26

0.70

0.21–2.34

1.07

0.37–3.13

Comorbid substance

No (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

use disorder

Yes

1.92

0.54–6.86

*4.48

1.11–18.08

2.46

0.59–10.30

1.46

0.39–5.48

1.78

0.46–6.95

3.21

0.81–12.75

1.27

0.33–4.82

0.98

0.28–3.42

Comorbid

No (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

personality disorder

Yes

1.87

0.49–7.20

1.40

0.34–5.84

1.55

0.38–6.35

2.20

0.55–8.70

1.76

0.41–7.51

2.05

0.49–8.48

4.03

0.97–16.83

2.24

0.61–8.26

Comorbid

No (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

other disorderf

Yes

0.89

0.23–3.41

0.51

0.12–2.12

0.26

0.06–1.10

2.36

0.59–9.45

1.48

0.35–6.22

0.43

0.11–1.77

1.02

0.25–4.11

1.24

0.32–4.72

More than 1 anxiety

No (ref.)

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

1.00

-

disorder

Yes

0.59

0.15–2.31

0.45

0.10–1.96

0.64

0.16–2.53

0.97

0.22–4.19

0.74

0.16–3.35

0.99

0.25–3.96

1.90

0.45–8.01

0.80

0.21–2.97

  1. OR Adjusted odds ratio; 95 % CI 95 % confidence interval
  2. *p < 0.05; **p < 0.01; ***p < 0.001. These p-values indicate a significance of the difference of the odds ratios between categories tested by χ2-test. Significant differences (p < 0.05) in boldface
  3. aAntidepressant or buspirone prescribed
  4. bAt least 1 visit with a physician a year
  5. cAntidepressant or buspirone used for at least 2 months + 4 visits with a physician a year
  6. dAt least 1 session of psychotherapy a year
  7. eAntidepressant or buspirone used for at least 2 months + at least 4 visits with a physician a year or at least 8 sessions of psychotherapy a year or a hospitalization for anxiety disorders lasting for at least 4 days
  8. fPsychotic, eating, sleeping, adjustment or impulse control disorder, lifetime
  9. gParticipants with a single specific phobia were excluded
  10. hAll the variables were entered simultaneously into a logistic regression model, adjusting for the other factors shown in the table